News

Investigators working to stem the spread of antibiotic-resistant bacteria have taken a major step in their efforts to develop new treatments. In mBio, researchers at the University of Texas Health Science Center at Houston (UTHealth) report they have identified a novel mechanism that a particular superbug uses to fend off a key front-line antibiotic called daptomycin. The superbug often affects critically ill patients. This information is helping investigators identify compounds to knock out a mechanism of resistance in order to disarm the superbug.